The relationship between variables of 123-I-metaiodobenzylguanidine cardiac imaging and clinical status of the patients with diastolic heart failure

International Journal of Cardiology

Volumn 113, Issue 2, 2006, Pages 223-228

  Sugiura, Masato ^a   Yamamoto, Koji ^b   Takeda, Yutaka ^a   Takeda, Yasuko ^a   Dohmori, Takemasa ^a   Ogata, Masaki ^a   Kondo, Hiroaki ^a   Suzuki, Shogo ^b   Fukutomi, Tatsuya ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Cardiac sympathetic nerve; Neurohumoral factors; Scintigraphy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EVALUATION; EXERCISE; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; STANDARDIZATION;

3-IODOBENZYLGUANIDINE; AGED; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; FOLLOW-UP STUDIES; GATED BLOOD-POOL IMAGING; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MYOCARDIAL CONTRACTION; PROGNOSIS; RADIOPHARMACEUTICALS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 33750445618     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.11.017     Document Type: Article

References (24)

1. Porter T.R., Eckberg D.L., Fritsch J.M., et al. Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. J Clin Invest 85 (1990) 1362-1371
2. Bristow M.R., Minobe W., Rasmussen R., et al. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 89 (1992) 803-815
3. Wieland D.M., Brown L.E., and Rogers L. Myocardial imaging with a radioiodinated norepinephrine storage analogue. J Nucl Med 22 (1881) 22-31
4. Cohen-Solal A., Esanu Y., Logeart D., et al. Cardiac methoiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 33 (1999) 759-766
5. de Milliano P.A., van Eck-Smit B.L., van Zwieten P.A., de Groot A.C., Tijssen J.G., and Lie K.I. Relationship between cardiac metaiodobenzylguanidine uptake and homodynamic, functional and neurohumoral parameters in patients with heart failure. Eur J Heart Fail 3 (2001) 693-697
6. Ogita H., Shimonagata T., Fukunami M., et al. Prognostic significance of cardiac (123) I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study. Heart 86 (2001) 656-660
7. Imamura Y., Fukuyama T., Mochizuki T., Miyagawa M., and Watanabe K. Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy. Jpn Circ J 65 (2001) 155-160
8. Matsui T., Tsutamoto T., Maeda K., Kusukawa J., and Kinoshita M. Prognostic value of repeated 123-I-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments: comparison with neurohumoral factors. Circ J 65 (2002) 537-543
9. Ishida Y. Nuclear imaging. In: Kitamura S., Miyatake K., and Yutani C. (Eds). Advanced heart failure (2003), Igakushoin, Tokyo 112-126
10. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community: a study of all incident cases in Olmsted Country, Minnesota, in 1991. Circulation 98 (1988) 2282-2289
11. Zile M.R., and Brutsaert D.L. New concept in diastolic dysfunction and diastolic heart failure: part 1. Circulation 105 (2002) 1387-1393
12. Henry W.L., DeMaria A.N., Gramak R., et al. Report of the American Society of Echocardiography Committee on nomenclature and standards in two-dimensional echocardiography. Circulation 62 (1980) 212-217
13. Takeda Y., Fukutomi T., Suzuki S., et al. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction. Am J Cardiol 94 (2004) 448-453
14. Bergstrom A., Andersson B., Edner M., Nylander E., Persson H., and Dahlstrom U. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail 6 (2004) 453-461
15. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 109 (2004) 3176-3181
16. Nakata T., Nagao K., Tsuchihashi K., Hashimoto A., Tanaka S., and Iimura O. Regional cardiac sympathetic nerve dysfunction and the diagnostic efficacy of metaiodobenzylguanidine tomography in stable coronary artery disease. Am J Cardiol 78 (1996) 292-297
17. Imamura Y., Ando H., Mitsuoka W., et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol 26 (1995) 1594-1599
18. Hasking G.J., Esler M.D., Jennings G.L., Dewar E., and Lambert G. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73 (1986) 615-621
19. Swedberg K., Viquerat C., Rouleau J.L., et al. Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. Am J Cardiol 54 (1984) 783-786
20. Eisenhofer G., Esler M.D., Meredith I.T., et al. Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycerol and norepinephrine. Circulation 85 (1992) 1775-1785
21. Eisenhofer G., Friberg P., Rundqvist B., et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 93 (1996) 1667-1676
22. Rose C., BUrgess J.H., and Cousineau D. Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload. J Clin Invest 76 (1985) 740-747
23. Bohm M., La Rosee K., Schwinger R.H., and Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 25 (1995) 146-153
24. Rankin S.L., Briffa T.G., Morton A.R., and Hung J. A specific activity questionnaire to measure the functional capacity of cardiac patients. Am J Cardiol 77 (1996) 1220-1223